147 related articles for article (PubMed ID: 1676428)
1. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.
Gazit A; Osherov N; Posner I; Yaish P; Poradosu E; Gilon C; Levitzki A
J Med Chem; 1991 Jun; 34(6):1896-907. PubMed ID: 1676428
[TBL] [Abstract][Full Text] [Related]
2. Tyrphostins. 3. Structure-activity relationship studies of alpha-substituted benzylidenemalononitrile 5-S-aryltyrphostins.
Gazit A; Osherov N; Posner I; Bar-Sinai A; Gilon C; Levitzki A
J Med Chem; 1993 Nov; 36(23):3556-64. PubMed ID: 7902440
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins.
Osherov N; Gazit A; Gilon C; Levitzki A
J Biol Chem; 1993 May; 268(15):11134-42. PubMed ID: 8098709
[TBL] [Abstract][Full Text] [Related]
4. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
Gazit A; Yaish P; Gilon C; Levitzki A
J Med Chem; 1989 Oct; 32(10):2344-52. PubMed ID: 2552117
[TBL] [Abstract][Full Text] [Related]
5. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
Gazit A; Osherov N; Gilon C; Levitzki A
J Med Chem; 1996 Dec; 39(25):4905-11. PubMed ID: 8960549
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
Klein JM; McCarthy TA
Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
[TBL] [Abstract][Full Text] [Related]
7. Tyrphostins suppress the growth of psoriatic keratinocytes.
Ben-Bassat H; Vardi DV; Gazit A; Klaus SN; Chaouat M; Hartzstark Z; Levitzki A
Exp Dermatol; 1995 Apr; 4(2):82-8. PubMed ID: 7640880
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
Brunton VG; Lear MJ; McKeown P; Robins DJ; Workman P
Anticancer Drug Des; 1996 Sep; 11(6):463-83. PubMed ID: 8836111
[TBL] [Abstract][Full Text] [Related]
10. Structural studies on bioactive compounds. 32. Oxidation of tyrphostin protein tyrosine kinase inhibitors with hypervalent iodine reagents.
Wells G; Seaton A; Stevens MF
J Med Chem; 2000 Apr; 43(8):1550-62. PubMed ID: 10780912
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
Nowak F; Jacquemin-Sablon A; Pierre J
Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moieties.
Brunton VG; Lear MJ; Robins DJ; Williamson S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):291-309. PubMed ID: 7916898
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.
Ohmichi M; Pang L; Ribon V; Gazit A; Levitzki A; Saltiel AR
Biochemistry; 1993 May; 32(17):4650-8. PubMed ID: 7683492
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
Aflalo E; Iftach S; Segal S; Gazit A; Priel E
Cancer Res; 1994 Oct; 54(19):5138-42. PubMed ID: 7923131
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cardiac adenylyl cyclase by epidermal growth factor (EGF). Role of EGF receptor protein tyrosine kinase activity.
Nair BG; Patel TB
Biochem Pharmacol; 1993 Oct; 46(7):1239-45. PubMed ID: 8216375
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
Suarez Pestana E; Greiser U; Sánchez B; Fernández LE; Lage A; Perez R; Böhmer FD
Br J Cancer; 1997; 75(2):213-20. PubMed ID: 9010029
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.
Esther A; Iftach S; Esther P
FEBS Lett; 1994 Mar; 341(1):99-103. PubMed ID: 8137930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
